ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds

September 24, 2010

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007